Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Aurelio Marsiglio"'
Autor:
Jürgen Moll, Daniele Fancelli, Enrico Pesenti, Dario Ballinari, Aurelio Marsiglio, Veronica Patton, Cristina Alli, Chiara Soncini, Claudio Arrigoni, Paola Zugnoni, Paola Storici, Luisa Rusconi, Paola Vianello, Maurizio Rocchetti, Gemma Texido, Anna Degrassi, Valter Croci, Laura Gianellini, Paolo Cappella, Maria Laura Giorgini, Roberta Ceruti, Patrizia Carpinelli
Supplementary Fig. S1 from PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ad37abd8e1e506016be814b1b51c632
https://doi.org/10.1158/1535-7163.22483142.v1
https://doi.org/10.1158/1535-7163.22483142.v1
Autor:
Jürgen Moll, Daniele Fancelli, Enrico Pesenti, Dario Ballinari, Aurelio Marsiglio, Veronica Patton, Cristina Alli, Chiara Soncini, Claudio Arrigoni, Paola Zugnoni, Paola Storici, Luisa Rusconi, Paola Vianello, Maurizio Rocchetti, Gemma Texido, Anna Degrassi, Valter Croci, Laura Gianellini, Paolo Cappella, Maria Laura Giorgini, Roberta Ceruti, Patrizia Carpinelli
Supplementary Table S1 from PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c070b33c5aefdf25ed1f037d109f678
https://doi.org/10.1158/1535-7163.22483139.v1
https://doi.org/10.1158/1535-7163.22483139.v1
Autor:
Jürgen Moll, Daniele Fancelli, Enrico Pesenti, Dario Ballinari, Aurelio Marsiglio, Veronica Patton, Cristina Alli, Chiara Soncini, Claudio Arrigoni, Paola Zugnoni, Paola Storici, Luisa Rusconi, Paola Vianello, Maurizio Rocchetti, Gemma Texido, Anna Degrassi, Valter Croci, Laura Gianellini, Paolo Cappella, Maria Laura Giorgini, Roberta Ceruti, Patrizia Carpinelli
PHA-739358 is a small-molecule 3-aminopyrazole derivative with strong activity against Aurora kinases and cross-reactivities with some receptor tyrosine kinases relevant for cancer. PHA-739358 inhibits all Aurora kinase family members and shows a dom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebb0bde1377ecffa21e6fcbd2a5240d3
https://doi.org/10.1158/1535-7163.c.6531083.v1
https://doi.org/10.1158/1535-7163.c.6531083.v1
Autor:
Michele Caruso, Arianna Pina, Fabio Gasparri, Laura Belvisi, Daniela Arosio, Simone Zanella, Ulisse Cucchi, Daniele Donati, Cesare Gennari, Ivan Fraietta, Clara Albanese, Luca Pignataro, A. Dal Corso, Aurelio Marsiglio
Publikováno v:
ChemistrySelect 2 (2017). doi:10.1002/slct.201701052
info:cnr-pdr/source/autori:Pina A.; Dal Corso A.; Caruso M.; Belvisi L.; Arosio D.; Zanella S.; Gasparri F.; Albanese C.; Cucchi U.; Fraietta I.; Marsiglio A.; Pignataro L.; Donati D.; Gennari C./titolo:Targeting Integrin ?V?3 with Theranostic RGD-Camptothecin Conjugates Bearing a Disulfide Linker: Biological Evaluation Reveals a Complex Scenario/doi:10.1002%2Fslct.201701052/rivista:ChemistrySelect/anno:2017/pagina_da:/pagina_a:/intervallo_pagine:/volume:2
info:cnr-pdr/source/autori:Pina A.; Dal Corso A.; Caruso M.; Belvisi L.; Arosio D.; Zanella S.; Gasparri F.; Albanese C.; Cucchi U.; Fraietta I.; Marsiglio A.; Pignataro L.; Donati D.; Gennari C./titolo:Targeting Integrin ?V?3 with Theranostic RGD-Camptothecin Conjugates Bearing a Disulfide Linker: Biological Evaluation Reveals a Complex Scenario/doi:10.1002%2Fslct.201701052/rivista:ChemistrySelect/anno:2017/pagina_da:/pagina_a:/intervallo_pagine:/volume:2
Theranostic RGD-camptothecin conjugates, possessing a disulfide linker and a fluorescent naphthalimide moiety, were synthesized and biologically evaluated. The conjugates showed nanomolar affinity for the purified ?V?3-integrin receptor. For antiprol
Autor:
Arturo Galvani, Nilla Avanzi, Giovanni Cervi, Barbara Salom, Marisa Montemartini, Daniela Faiardi, Claudia Piutti, Gianpaolo Fogliatto, Daniele Donati, Gianluca Papeo, Christian Orrenius, Danilo Mirizzi, Elena Casale, Aurelio Marsiglio, Francesco Casuscelli, Ferguson Ron, Matteo D'anello, Eduard R. Felder, Elena Ardini
Publikováno v:
Bioorganic & Medicinal Chemistry. 21:7364-7380
A novel series of PIM inhibitors was derived from a combined effort in natural product-inspired library generation and screening. The novel pyrrolo[1,2-a]pyrazinones initial hits are inhibitors of PIM isoforms with IC50 values in the low micromolar r
Autor:
Barbara Valsasina, Michele Caruso, Simona Rizzi, Arturo Galvani, Sonia Troiani, Eduard R. Felder, Ivan Fraietta, Nicoletta Colombo, Marina Ciomei, Italo Beria, Paolo Orsini, Ulisse Cucchi, Carlo Visco, Fabio Gasparri, Sabrina Cribioli, Clara Albanese, Rita Perego, Ilaria Candiani, Attilio Tomasi, Daniele Donati, Antonella Isacchi, Aurelio Marsiglio
Publikováno v:
Cancer Research. 78:734-734
Thienoindoles are a new proprietary class of highly potent DNA minor groove alkylating agents. This class is characterized by a fused thiophene ring whose intrinsic electron-withdrawing character provides a nearly optimal increase in stability and po
Autor:
Daniela Arosio, Michele Caruso, Francesco Sola, Clara Albanese, Umberto Piarulli, Daniele Donati, Laura Belvisi, Fabio Gasparri, Cesare Gennari, Luca Pignataro, Barbara Valsasina, Sonia Troiani, Alberto Dal Corso, Aurelio Marsiglio
Publikováno v:
Chemistry (Weinh., Print) 21 (2015): 6921–6929. doi:10.1002/chem.201500158
info:cnr-pdr/source/autori:Dal Corso, Alberto; Caruso, Michele; Belvisi, Laura; Arosio, Daniela; Piarulli, Umberto; Albanese, Clara; Gasparri, Fabio; Marsiglio, Aurelio; Sola, Francesco; Troiani, Sonia; Valsasina, Barbara; Pignataro, Luca; Donati, Daniele; Gennari, Cesare/titolo:Synthesis and Biological Evaluation of RGD Peptidomimetic-Paclitaxel Conjugates Bearing Lysosomally Cleavable Linkers/doi:10.1002%2Fchem.201500158/rivista:Chemistry (Weinh., Print)/anno:2015/pagina_da:6921/pagina_a:6929/intervallo_pagine:6921–6929/volume:21
info:cnr-pdr/source/autori:Dal Corso, Alberto; Caruso, Michele; Belvisi, Laura; Arosio, Daniela; Piarulli, Umberto; Albanese, Clara; Gasparri, Fabio; Marsiglio, Aurelio; Sola, Francesco; Troiani, Sonia; Valsasina, Barbara; Pignataro, Luca; Donati, Daniele; Gennari, Cesare/titolo:Synthesis and Biological Evaluation of RGD Peptidomimetic-Paclitaxel Conjugates Bearing Lysosomally Cleavable Linkers/doi:10.1002%2Fchem.201500158/rivista:Chemistry (Weinh., Print)/anno:2015/pagina_da:6921/pagina_a:6929/intervallo_pagine:6921–6929/volume:21
Two small-molecule-drug conjugates (SMDCs, 6 and 7) featuring lysosomally cleavable linkers (namely the Val-Ala and Phe-Lys peptide sequences) were synthesized by conjugation of the alpha(v)beta(3)-integrin ligand cyclo[DKP-RGD]-CH2NH2 (2) to the ant
Autor:
Paolo Magni, Dario Ballinari, M. Rocchetti, Giuseppe De Nicolao, Massimiliano Germani, Italo Poggesi, Aurelio Marsiglio
Publikováno v:
Cancer Chemotherapy and Pharmacology. 52:507-513
The effect of an anticancer treatment on tumor cell proliferation in vitro can be described as a three-dimensional surface where the inhibitory effect is related to drug concentration and treatment time. The analysis of this kind of response surface
Autor:
Francesco Sola, Maria Grandi, Mariella Farao, Enrico Pesenti, Nicola Mongelli, Aurelio Marsiglio
Publikováno v:
Cancer Chemotherapy and Pharmacology. 36:217-222
FCE 26644, or 7,7'-(carbonyl-bis[imino-N-methyl-4, 2 pyrrole carbonyl-imino(N-methyl-4,2-pyrrole)carbonyl-imino])-bis-(1,3- naphthalene)disulfonic acid, belongs to the newly synthesized class of sulfonated derivatives of distamycin A. FCE 26644 is a
Autor:
Marina Ciomei, Sonia Troiani, Arturo Galvani, Ivan Fraietta, Michele Caruso, Eduard R. Felder, Italo Beria, Nicoletta Colombo, Francesco Sola, Ulisse Cucchi, Sabrina Cribioli, Clara Albanese, Fabio Gasparri, Carlo Visco, Enrico Pesenti, Rita Perego, Aurelio Marsiglio, Simona Rizzi, Antonella Isacchi, Barbara Valsasina, Paolo Orsini, Daniele Donati, Federico Riccardi Sirtori
Publikováno v:
Molecular Cancer Therapeutics. 14:A149-A149
Antibody-drug conjugates (ADCs) are increasingly employed in different oncology settings with more than forty products in clinical evaluation at present, and two approved drugs, ado-trastuzumab emtansine and brentuximab vedotin, respectively targetin